As of Dec 5, we're $10,600 in the red for the month. Donate here to support this vital work.
Subscribe here to our free email list

Mind-Altering Drugs News Stories
Excerpts of Key Mind-Altering Drugs News Stories in Major Media


Below are highly revealing excerpts of important mind-altering drugs news stories reported in the media that suggest a major cover-up. Links are provided to the full stories on their major media websites. If any link fails to function, read this webpage. These mind-altering drugs news stories are listed by date posted to this webpage. You can explore the same articles listed by order of importance or by article date. By choosing to educate ourselves on these important issues and to spread the word, we can and will build a brighter future.


Note: This comprehensive list of mind-altering drugs news stories is usually updated once a week. Explore our full index to revealing excerpts of key major media news stories on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.


Colorado voters legalize psilocybin and psychedelic therapy
2022-11-08, Denver Post
Posted: 2022-11-29 01:24:38
https://www.denverpost.com/2022/11/08/colorado-results-prop-122-legalizing-ps...

Colorado is poised to become the second U.S. state to legalize medicinal psychedelics. Proposition 122, Access to Natural Psychedelic Substances, was supported by about 52% of the vote ... according to the Secretary of State's Office. The measure legalizes psilocybin and psilocin, two compounds found in "magic mushrooms," for use in therapeutic settings and paves the way for the establishment of "healing centers" where adults 21 years old and up can use the substances under the supervision of licensed professionals. Additionally, Proposition 122 decriminalizes the personal growing, use and sharing of psilocybin and psilocin, as well as ibogaine, mescaline and dimethyltryptamine, or DMT, for adults. Colorado follows Oregon, which legalized psilocybin in 2020. Natural Medicine Colorado lauded the results as a history-making win. "Colorado voters saw the benefit of regulated access to natural medicines, including psilocybin, so people with PTSD, terminal illness, depression, anxiety and other mental health issues can heal," said the measure's co-proponents, Kevin Matthews and Veronica Lightening Horse Perez, in a statement. Proposition 122 gives the Department of Regulatory Agencies (DORA) until January 2024 to develop licensing criteria for psychedelic treatment centers, facilitators, and ancillary businesses.

Note: For more along these lines, see concise summaries of deeply revealing news articles on mind-altering drugs from reliable major media sources.


Key Articles From Years Past


Psychedelics And Mental Health: What Does The Science Say?
2022-09-02, Forbes
Posted: 2022-11-08 14:43:57
https://web.archive.org/web/20221021092440/https://www.forbes.com/health/mind...

Psychedelic therapy is the use of psychedelic substances, often alongside traditional talk therapy (psychotherapy), as a treatment for mental health issues such as anxiety, depression, suicidality and PTSD. Michael Mithoefer, M.D. ... at the Multidisciplinary Association for Psychedelic Studies (MAPS), likens psychedelic therapy to applying a cast to a broken bone. "[Psychedelic]-assisted therapy engages the mind's innate power to heal itself–the participants' 'inner healing intelligence,'" claims Dr. Mithoefer, going on to explain that "the source of the healing process is the person themselves–the psychedelic and therapists are catalysts." In the U.S., psychedelics continue to undergo medical trials, with some being granted a "breakthrough therapy" designation by the FDA, indicating that preliminary clinical evidence has shown the drug can demonstrate substantial improvement over currently available therapy. COMPASS Pathways, a mental health treatment company, received the designation for its psilocybin therapy for treatment-resistant depression in 2018. In 2019, Usona Institute ... received the designation to continue its testing of psilocybin as a treatment for major depressive disorder. Psilocybin-assisted therapy is also being tested as a treatment for various addictions ... as well as certain conditions such as anxiety, depression, post traumatic stress disorder (PTSD), obsessive compulsive disorder (OCD), cluster headaches, migraines and chronic pain.

Note: Read more about the healing potentials of psychedelic medicine. Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.


What Do Athletes Get From Ayahuasca, Mushrooms and Ecstasy?
2022-08-12, Sports Illustrated
Posted: 2022-11-08 14:42:24
https://www.si.com/more-sports/2022/08/12/psychedelics-sports-aaron-rodgers-d...

Aaron Rodgers and Kenny Stills are among the few who have spoken publicly about their use of psychedelics for mental health purposes. But a future where the treatment is more widespread across sports may not be so far away. "Some people still ... don't recognize these as legitimate, life-saving medical medicines," [NBA agent Daniel] Poneman says. "There are athletes that I know who have had life-changing experiences with these medicines, but only a few of them are brave enough to speak out for fear of being stigmatized." There's still stigma around taking medication of any kind for mental illness, but it's slowly lessening. Aaron Rodgers said on a recent podcast that he has taken psychedelics to improve his mental health. The Packers' quarterback said he does not identify as having a mental illness like depression or anxiety, but that his most recent psychedelic experience–with ayahuasca, in March 2020, in Peru–has helped increase his "self-love." Before Rodgers spoke out, NFL free-agent wide receiver Kenny Stills was thought to be the only active professional athlete vocal about his psychedelic use. Stills, who last season played for the Saints, says his case of depression in 2016 felt like a "permanent cloud." Last year he went to a clinic run by Field Trip Health, a for-profit that provides people with ketamine-assisted psychotherapy–meaning they have to take the medication under supervision of a licensed therapist and debrief with them afterward.

Note: Read more about the healing potentials of psychedelic medicine. Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.


Psilocybin as mental health therapy? Here's what I found.
2022-09-05, Washington Post
Posted: 2022-10-02 22:04:26
https://www.washingtonpost.com/health/2022/09/05/psilocybin-mental-health-psy...

A few weeks ago, I mentioned to a friend that I was interested in learning more about psychedelics, especially how they might help me with depression and anxiety. That's a broad category of plant medicines including psilocybin ("magic") mushrooms, MDMA (ecstasy), DMT (Dimitri or the Businessman's Trip), ketamine ("special K") and some others. My friend told me he'd recently taken his first "trip," which he described as life-changing. I asked him – a real estate developer living in Northern California, married with kids – why he decided to try a psychedelic substance. "My work felt increasingly stale and meaningless," he explained to me over a beer. "Despite a massive amount of reflection and coaching around how to break the rut, I felt as though I was still off track." When I confided my interest in psychedelics to a few other friends, several said they had tried the drugs and experienced several benefits: from easing anxiety to finding spiritual insights to combating depression and, among some with cancer, helping to reduce the fear of dying. They are hardly outliers. According to a new YouGovAmerica study, "one in four Americans say they've tried at least one psychedelic drug," amounting to some 72 million U.S. adults. When I queried my psychiatrist about participating to help improve my mental health, he was supportive, with two caveats: Do it with a trained therapist or guide, and do your best to ensure that the substance is what it's said to be.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the healing potentials of mind-altering drugs from reliable major media sources.


Altering Perceptions on Psychedelics
2022-04-01, Harvard Medicine
Posted: 2022-08-21 18:03:59
https://hms.harvard.edu/magazine/viral-world/altering-perceptions-psychedelics

Growing evidence for the safety and efficacy of psychedelics could lead to better treatments for anxiety, depression, pain, and other often intractable conditions. Jerry Rosenbaum was intrigued when he first heard about the effect that psilocybin–the hallucinogenic compound found in certain species of mushrooms–was purported to have on the brain's "resting state," what neuroscientists call the default mode network. The default mode network encompasses any neural function that has some bearing on our autobiographical tendencies. When people take psilocybin at low doses, the default mode network becomes less active. That is, the drug appears to tame self-reflection and all but ruin rumination, that obsessive mental state characterized by excessive, repetitive thoughts. Rumination is a hallmark cognitive symptom of depression. Neuroscientists are observing that, when taken in a controlled setting, these substances are beneficial to the brain, especially for people who have certain psychiatric disorders. Landmark studies in 2014 and 2016 showed that LSD and psilocybin alleviated existential anxiety in patients with life-threatening illnesses for up to a year after beginning the treatment. Other studies have shown that ketamine may strengthen neurons against the damage from chronic stress by preventing synapses from being flooded with glutamate, an amino acid that, in excess, withers dendrites. And researchers continue to investigate whether psychedelics are useful as anti-inflammatory agents.

Note: Read more about the healing potentials of psychedelic medicine. Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.


MAPS Raises Nearly $1.6 Million in Christie's NFT Auction
2022-06-30, Yahoo News
Posted: 2022-08-21 18:02:19
https://www.yahoo.com/now/maps-raises-nearly-1-6-191900137.html

The Multidisciplinary Association for Psychedelic Studies (MAPS) has announced that Cartography of the Mind: A Curated NFT Sale raised $1,569,960. Proceeds of the auction, presented by Christies in collaboration with Ryan Zurrer, founder of Dialectic and Vine Ventures, will benefit MAPS. Throughout the week, the physical exhibition at Christie's new gallery on 6th Avenue drew impressive crowds of enthusiastic visitors. With competitive bidding, the sale realized over $1.5 million. It was 100% sold, and 130% sold hammer over low estimate. Beeple, David Choe, Sarah Meyohas, Refik Anadol, Mad Dog Jones, IX Shells, and more donated art to support MAPS. The research, education, and advocacy organization ... remains the leading body at the vanguard of research into potentially life-saving psychedelic-assisted therapies. Psychedelic Healing is an artistic interpretation of the MAPS logo by renowned artist Alex Grey to celebrate MAPS' 35th anniversary in 2021. It was purchased by Ryan Zurrer and donated back to MAPS for additional fundraising. Founded in 1986, MAPS is a 501(c)(3) non-profit research and educational organization developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana. MAPS is sponsoring the most advanced psychedelic therapy research in the world funded primarily by philanthropic donors and grantors who have given more than $130 million for research and education.

Note: Read more about the healing potentials of psychedelic medicine. Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.


Biden Administration Plans for Legal Psychedelic Therapies Within Two Years
2022-07-26, The Intercept
Posted: 2022-08-15 21:17:49
https://theintercept.com/2022/07/26/mdma-psilocybin-fda-ptsd/

As twin mental health and drug misuse crises kill thousands of people per week, the potential of psychedelic-assisted therapies "must be explored," urges a federal letter on behalf of the U.S. health secretary. President Joe Biden's administration "anticipates" that regulators will approve MDMA and psilocybin within the next two years for designated breakthrough therapies for PTSD and depression, respectively. The administration is "exploring the prospect of establishing a federal task force to monitor" the emerging psychedelic treatment ecosystem, according to the letter sent by Assistant Secretary for Mental Health and Substance Use. The move followed [the] introduction of a bipartisan bill, co-sponsored by Sens. Cory Booker, D-N.J., and Rand Paul, R-Ky., to force the DEA to stop barring terminally ill patients from trying controlled drugs which have passed early trials. The right to try experimental therapies has been enshrined in federal law since 2018, but the DEA currently blocks its use among people with late-stage cancer who wish to be treated with psilocybin, a Schedule I controlled substance. "Studies have shown that psilocybin produces substantial and sustained decreases in depression and anxiety among patients with life-threatening cancer," Booker wrote. "While typically terminally ill patients are allowed to access drugs that are in FDA clinical trials, they are barred from accessing Schedule I drugs, despite their therapeutic potential."

Note: Read more about the healing potentials of psychedelic medicine. Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.


Veterans Have Become Unlikely Lobbyists in Push to Legalize Psychedelic Drugs
2021-11-11, New York Times
Posted: 2022-07-04 12:59:31
https://www.nytimes.com/2021/11/11/health/veterans-psychedelics-ptsd-depressi...

Jose Martinez, a former Army gunner whose right arm and both legs were blown off by a roadside bomb in Afghanistan, has a new calling: He's become one of the most effective lobbyists in a campaign to legalize the therapeutic use of psychedelic drugs across the country. On a Zoom call ... with Connie Leyva, a Democratic legislator in California who has long opposed relaxing drug laws, Mr. Martinez told her how psilocybin, the psychoactive ingredient in "magic" mushrooms, had helped to finally quell the physical pain and suicidal thoughts that had tormented him. Ms. Leyva says she changed her mind even before the call ended, and she later voted yes on the bill, which is expected to become law early next year. In the two years since Oregon, Washington, D.C., and a half-dozen municipalities decriminalized psilocybin, vets have become leading advocates in the drive to legalize psychedelic medicine, which they credit with helping ease the post-traumatic stress, anxiety and depression that are often tied to their experiences in the military. The campaign has been propelled by the epidemic of suicides among veterans ... but also by the national reckoning over the mass incarceration of people on drug charges. More than 30,000 service members have taken their own lives in the years since Sept. 11 – four times the number of those who died on the battlefield. "I will not be told no on something that prevents human beings from killing themselves," Mr. Martinez said.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the healing potentials of mind-altering drugs from reliable major media sources.


A Balm for Psyches Scarred by War
2022-05-29, New York Times
Posted: 2022-07-04 12:57:51
https://www.nytimes.com/2022/05/29/health/mdma-therapy-ptsd.html

Mr. McCourry, a former U.S. Marine, had been crippled by post-traumatic stress disorder ever since returning from Iraq in 2004. He could not sleep, pushed away friends and family and developed a drinking problem. The numbness he felt was broken only by bouts of rage and paranoia. He was contemplating suicide when his sister heard about a novel clinical trial using the psychedelic drug MDMA, paired with therapy, to treat PTSD. Desperate, he enrolled in 2012. PTSD is a major public health problem worldwide and is particularly associated with war. In the United States, an estimated 13 percent of combat veterans and up to 20 to 25 percent of those deployed to Iraq and Afghanistan are diagnosed with PTSD at some point in their lives, compared with seven percent of the general population. There is growing evidence that MDMA – the illegal drug known as Ecstasy or Molly – can significantly lessen or even eliminate symptoms of PTSD when the treatment is paired with talk therapy. Last year, scientists reported in Nature Medicine the most encouraging results to date. The 90 participants in the study had all suffered from severe PTSD for more than 14 years on average. Each received three therapy sessions with either MDMA or a placebo, spaced one month apart and overseen by a two-person therapist team. Two months after treatment, 67 percent of those who received MDMA no longer qualified for a PTSD diagnosis, compared with 32 percent who received the placebo. As in previous trials, MDMA caused no serious side effects.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the healing potentials of mind-altering drugs from reliable major media sources.


A Long, Strange Trip to the Mainstream for Psychedelics
2021-03-12, Boston Globe
Posted: 2022-05-23 20:39:03
https://www.bostonglobe.com/2021/03/12/opinion/long-strange-trip-mainstream-p...

Massachusetts General Hospital wouldn't seem like a natural fit for a center devoted to mind-altering drugs. But this week, MGH launched the Center for the Neuroscience of Psychedelics to study the potential of psilocybin and other psychoactive drugs to treat conditions such as depression, addiction, trauma, and more. The new center at MGH signifies that the field of psychedelic therapy has arrived. Inspiration came from the search for ways to ease the misery of patients whose mental illness is resistant to traditional treatments. Psychedelics are known to facilitate "plasticity" in the brain, increasing its capacity for change, and [director Jerrold] Rosenbaum said his team wanted to understand how these agents "move the brain to change in a way that can address many of the most anguishing forms of human suffering." The MGH center combines the disciplines of psychiatry, brain imaging, genomic medicine, and chemical biology. Some of the initial work involving patients will use psilocybin and be directed at rumination – the stuck, repetitive thought patterns that underlie several conditions, from addiction to obsessive-compulsive disorder. The future of the center's research is boundless, since psychedelics' role in neuroplasticity and neuritogenesis – the ability to build new synapses – may be useful in palliative care with terminally ill patients as well as in combatting neurodegenerative diseases such as Parkinson's and Alzheimer's.

Note: This article is also available on this webpage. For more along these lines, see concise summaries of deeply revealing news articles on mind-altering drugs from reliable major media sources.


Can magic mushrooms be used to treat racial trauma?
2022-03-28, The Guardian (One of the UK's leading newspapers)
Posted: 2022-05-02 23:08:52
https://www.theguardian.com/lifeandstyle/2022/mar/28/magic-mushrooms-racial-t...

Evan, a middle-class Black man, doesn't come across as a psychedelic enthusiast. He's a 23-year-old quantitative economics graduate student who takes pride in steaming his sweater vests to maintain a studious appearance. In 2015, Evan's father was arrested for misdemeanor drug possession. A teenager at the time, he swore off drugs forever. But six years later, magic mushrooms have become Evan's remedy to cope with racial trauma. Like most Americans, Evan followed the widespread media coverage of George Floyd and Breonna Taylor's deaths in 2020. And like many Black Americans, he experienced traumatic-stress symptoms triggered by the constant exposure to cases of police brutality and racial discrimination. Debilitating panic attacks incapacitated him multiple times a day; insomnia drained his ... energy. After unsuccessfully trying three different anti-anxiety medications, he finally stumbled upon a study on psychedelics for racial trauma. He wondered: could psychedelic therapy be the solution? Psilocybin, the active compound in magic mushrooms, has been found to mitigate acute anxiety among patients with life-threatening cancer. A state-sponsored study in Texas is investigating psychedelics as a treatment for post-traumatic stress disorder in veterans. But one lesser-known benefit has been documented by researchers at the University of Ottawa: psychedelics may alleviate symptoms of race-based traumatic stress.

Note: Read more about the healing potentials of mind-altering drugs. Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.


Can MDMA Save a Marriage?
2022-02-08, New York Times
Posted: 2022-03-14 17:25:35
https://www.nytimes.com/2022/02/08/well/mind/marriage-molly-mdma.html

After 10 years of marriage, Ree, 42, and her husband were ready to call it quits. Then a friend suggested that they try the illegal drug MDMA, popularly known as Ecstasy or Molly. For Ree ... the answer was an "immediate no." Six months later, after reading "How to Change Your Mind," the best-selling book by Michael Pollan that details his transformative experience with psychedelics, Ree reconsidered. And that's how they found themselves in a secluded area of Utah at a large, rented house with a beautiful view of the mountains to trip on MDMA with five other couples. During their first trip on MDMA, Ree said she and her husband tearfully discussed things they had trouble speaking about for the last decade: How his emotional withdrawal had affected her self-esteem, and how sorry she was that she had continually pushed him to open up without understanding the pain he held inside. "My husband started sharing with me for the first time all these thoughts and emotions," Ree said. "It was him without the walls," she added. They also cuddled in bed for hours, skin to skin, describing all the things they loved about one another. "For a person who has always had body image issues, to allow him to touch me – touch my stomach, the part of me I don't love, was incredibly healing," she said. They continued using MDMA about twice a year to help them have difficult conversations. They both started seeing therapists. Now, about three years after they first tried MDMA ... they no longer need the drug to speak openly with one another.

Note: Read more about the healing potentials of mind-altering drugs. Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.


A Psychedelic May Soon Go to the FDA for Approval to Treat Trauma
2022-02-01, Scientific American
Posted: 2022-03-06 22:46:38
https://www.scientificamerican.com/article/a-psychedelic-may-soon-go-to-the-f...

Berra Yazar-Klosinski [is the] chief scientific officer at the Multidisciplinary Association for Psychedelic Studies (MAPS). I ... committed to working with her on the phase 3 program that would assess the efficacy and safety of MDMA–known recreationally as Molly or Ecstasy–for severe PTSD, or post-traumatic stress disorder. Although more than half a dozen phase 2 studies have demonstrated the effectiveness and safety of MDMA for PTSD, early trials often fail to accurately predict the outcome of the larger, multisite phase 3 trials that follow. In the case of MDMA, we have been lucky. At 15 study sites across three countries, working with more than 70 different therapists and with study participants with childhood trauma, depression and a treatment-resistant subtype of PTSD, we have obtained incredibly promising results. Phase 3 study participants receiving MDMA-assisted therapy showed a greater reduction in PTSD symptoms and functional impairment than participants receiving placebo plus therapy. In addition, their symptoms of depression plummeted. By the end of the study more than 67 percent of the participants in the MDMA group no longer met criteria for PTSD. An additional 21 percent had a clinically meaningful response–in other words, a lessening of anxiety, depression, vigilant mental states, and emotional flatness. MDMA-assisted therapy did not increase measures of suicidal thinking or behavior. MDMA also did not demonstrate any measurable misuse potential.

Note: Read more about the healing potentials of mind-altering drugs. Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.


It's Been A Banner Year For MAPS Public Benefit Corporation And The Women Leading It
2021-12-29, Forbes
Posted: 2022-02-07 12:27:11
https://www.forbes.com/sites/amandasiebert/2021/12/29/its-been-a-banner-year-...

In May, a long-awaited randomized, double-blind, placebo-controlled, Phase 3 clinical trial testing MDMA-assisted therapy for the treatment of PTSD was published in Nature Medicine. The trial was conducted by MAPS Public Benefit Corporation, a for-profit subsidiary launched by the registered non-profit in 2014, with the goal of conducting the necessary research to make MDMA a legally available medicine. "We are a for-profit, but we're wholly owned. We only have one shareholder, and it's a non-profit," says CEO Amy Emerson. While a non-profit is tax exempt and operates for charity, the PBC, like a traditional corporation, pays taxes, operates for profit, and has shareholders and stocks. The results of the Phase 3 clinical trial conducted by MAPS PBC revealed that after receiving a combination of talk therapy and MDMA, 67 percent of participants who received the drug no longer met the diagnostic criteria for PTSD, compared to 32 percent of participants who received the placebo. The trial was recently acknowledged as a "big win for the field" in Science Magazine's annual Breakthrough of the Year awards. "In our three-session model, there's no follow-up medication needed," [MAPS CMO Dr. Corine de Boer] says. After pooling the data of six Phase 2 trials together, de Boer's team found that 57 percent of participants no longer met the criteria for PTSD. At a one-year follow-up during which no MDMA was administered, that number increased to 67 percent.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the healing potentials of mind-altering drugs from reliable major media sources.


Jurvetson's Big Gift Shows How Psychedelics Capital Is Different
2021-12-06, Bloomberg
Posted: 2022-01-18 11:40:14
https://www.bloomberg.com/news/newsletters/2021-12-06/stephen-jurvetson-backs...

Psychedelics startups don't just want to just reinvent mental health. They also want to reinvent capitalism. And judging by the news coming out of last week's "Horizons: Perspectives on Psychedelics" conference in Manhattan, they're having some early success. Stephen Jurvetson, co-founder of Future Ventures and a board member at SpaceX, told me ... that he's a true believer in the industry's mission to fix the state of mental-health care. He decided last week to carve up his own estate by giving around half of his net worth to fund psychedelic science. Organizations like the public-benefit corporation of Multidisciplinary Association for Psychedelics Studies, or MAPS, and the Psychedelic Science Funders Collaborative, a nonprofit organization, have both accepted charitable donations but fund research that could lead to blockbuster drugs. Psychedelics startups do need funding, and badly. Like biotech, it's a high-risk industry with expensive clinical trials and regulatory uncertainty. And patents, a traditional financial engine for biotech, are harder to win for plants that have been around for centuries, or molecules that have already made the rounds as street drugs. MAPS also made a major announcement: The New York-based venture capital fund Vine Ventures has created a $70 million special purpose vehicle to fund its Phase 3 clinical trials on post-traumatic stress disorder and MDMA. The novel funding method ... will help keep MAPS a nonprofit while letting it retain control of its intellectual property.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the healing potentials of mind-altering drugs from reliable major media sources.


Psychedelic Therapy Is Poised To Create A Revolution In Mental Health
2021-11-23, Forbes
Posted: 2022-01-18 11:38:39
https://www.forbes.com/sites/davidcarpenter/2021/11/23/psychedelic-therapy-is...

Legal psychedelic medicine is poised to soon disrupt the multibillion-dollar mental health field. Treatments being trialed today in clinical settings using substances like psilocybin-containing mushrooms will soon offer legal alternatives to the more than 50 percent of patients receiving therapy for major depressive disorder (MDD) who do not respond to approved depression medications. The creation of new effective therapies will likely put pressure on healthcare providers to examine the upside of psychedelic therapies and how such treatments will inevitably affect their bottom line. While these therapies will not be a cure-all for everyone, over the next three to five years an expanding number of psychedelic treatments will produce alternatives for the many patients who find no relief from FDA-approved, first-line therapeutics like selective serotonin reuptake inhibitors (SSRIs). Since legalizing the use of psilocybin-containing magic mushrooms in 2020 through a ballot measure, Oregon is now in the process of creating an intricate statewide system for qualified caregivers to deliver psilocybin treatments in therapeutic settings. Sessions using psilocybin can last over six hours, which does not include vital therapy before and after treatments. MDMA-assisted therapy for severe post-traumatic stress disorder (PTSD), which is very close to being an FDA-approved therapy, will likewise require significant clinician involvement before, during and after a session.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the healing potentials of mind-altering drugs from reliable major media sources.


The worldview-changing drugs poised to go mainstream
2021-09-06, BBC News
Posted: 2021-10-11 15:45:14
https://www.bbc.com/future/article/20210906-what-if-everyone-took-psychedelics

In the last 10 years, psychedelic drugs like LSD, magic mushrooms, DMT, a host of "plant medicines" – including ayahuasca, iboga, salvia, peyote – and related compounds like MDMA and ketamine have begun to lose much of their 1960s-driven stigma. Promising clinical trials suggest that psychedelics may prove game-changing treatments for depression, PTSD and addiction. The response from the psychiatric community ... has been largely open-armed. The drugs may well mark the field's first paradigm shift since SSRIs in the 1980s. In 2017, for example, the US Food and Drug Administration designated MDMA a "breakthrough therapy", which meant it would be fast-tracked through to the second stage of Phase-3 trials. Psychedelics remain Schedule-1 drugs federally in the US and Class-A in the UK, but rules are relaxing. This wave of psychedelic enthusiasm in psychiatry isn't the first. They were originally heralded as wonder drugs in the 1950s. Across some 6,000 studies on over 40,000 patients, psychedelics were tried as experimental treatments for an extraordinary range of conditions: alcoholism, depression, schizophrenia, criminal recidivism, childhood autism. And the results were promising. From as little as a single LSD session, studies suggested that the drug relieved problem drinking for 59% of alcoholic participants. Experimenting with lower, so-called "psycholytic" doses, many therapists were amazed by LSD's power as an adjunct to talking therapy.

Note: Read more about the healing potentials of mind-altering drugs. Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.


Magic Mushrooms May Be the Biggest Advance in Treating Depression Since Prozac
2021-09-22, Newsweek
Posted: 2021-10-11 15:43:51
https://www.newsweek.com/2021/10/01/magic-mushrooms-may-biggest-advance-treat...

For most of his adult life, Aaron Presley, age 34, felt like a husk of a person, a piece of "garbage." Then, all at once, the soul-crushing, depressive fog started to lift, and the most meaningful experience of his life began. The turning point for Presley came as he lay on a psychiatrist's couch at Johns Hopkins University. He had consumed a large dose of psilocybin, the active ingredient in what's more commonly known as magic mushrooms, and entered a state that could best be described as lucid dreaming. Visions of family and childhood triggered overwhelming and long-lost feelings of love, he says. Presley was one of 24 volunteers taking part in a small study aimed at evaluating the effectiveness of a combination of psychotherapy and this powerful mind-altering drug to treat depression–an approach that, should it win approval, could be the biggest advance in mental health since Prozac in the 1990s. Depression ... affects 320 million people around the world. Roughly one-third of those who seek treatment won't respond to verbal or conventional drug therapies. Magic-mushroom therapy is offering some hope for these hopeless cases. In the Hopkins study, published last year in JAMA Psychiatry, the therapy was four times more effective than traditional antidepressants. Two-thirds of participants showed a more-than 50-percent reduction in depression symptoms after one week; a month later, more than half were considered in remission, meaning they no longer qualified as being depressed.

Note: Read more about the healing potentials of mind-altering drugs. Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.


Psychedelic trips could soon be part of therapy – here's what those sessions will look like
2021-07-24, CNBC News
Posted: 2021-08-29 18:20:48
https://www.cnbc.com/2021/07/24/how-psychedelic-assisted-therapy-with-mdma-an...

Psychedelic drugs are substances that alter perception and mood and affect a number of cognitive processes. The classic psychedelics include MDMA aka "ecstasy" or "molly," LSD, psilocybin or "mushrooms," ayahuasca and ibogaine. Used in conjunction with therapists, research has shown that psychedelics can help treat historically difficult-to-treat conditions by essentially "reshaping" the way "parts of the brain talk to each other," says Jennifer Mitchell, a neuroscientist. "Psychedelics allow for processing in a way that enables subjects to let go of things that had previously plagued them," she says. As Mitchell explains it, when people are young, their brains go through critical periods of learning and development that then become closed off as they age. Researchers believe that psychedelics "open those closed critical periods for just a tiny window of time," she says. "When that critical period is open again, you want to make the most of it, and make that potential change as positive as possible," she says. With psilocybin, for instance, it is believed the drug boosts connectivity in the brain and increases "neuroplastic states," which are the brain's ability to reorganize and adapt, says Dr. Stephen Ross ... who has been conducting clinical trials on psilocybin-assisted therapy for the past 16 years. MDMA-assisted therapy could be approved by the FDA for medical use as early as 2023, while other psychedelics, notably psilocybin, are waiting in the wings for their turn to be evaluated for medical purposes.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the healing potentials of mind-altering drugs from reliable major media sources.


Netflix documentary 'Fantastic Fungi' explores the many magical properties of mushrooms
2021-08-16, San Francisco Chronicle (San Francisco's leading newspaper)
Posted: 2021-08-29 18:19:22
https://www.sfgate.com/streaming/article/Netflix-documentary-Fantastic-Fungi-...

Fungi have been around for billions of years, setting the stage for humanity by supporting, carrying and converting life. But for complex political reasons, these organisms are still shrouded in mystery. One man, however, is determined to lift the veil on the magical world of mushrooms. Enter Stamets, a bespectacled author and researcher whose mission to decode nature's hidden language and explore "altered states of consciousness" is chronicled in the documentary "Fantastic Fungi," which was recently made available to stream on Netflix. While the film aims to destigmatize hallucinogenic mushrooms, it also demonstrates why we should legitimize the studies of all mushrooms. Contemporary experts in neurology, psychiatry and biology in the film show that fungal genomes can solve a host of mental, physical and environmental problems. From healing bacterial infections to cleaning petroleum spills, fungi possess unique, almost godlike properties that are otherwise unseen in nature. For instance, lion's mane, an edible white mushroom that tastes like lobster, stimulates nerves in order to grow, suggesting that it could potentially cure degenerative diseases like Alzheimer's. Ultimately, when Stamets discusses altered states of consciousness, it's ... about accepting a different state of being. For some people – especially those who live in pain – the film posits that mushrooms can be the answer they've been looking for.

Note: Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.


Important Note: Explore our full index to revealing excerpts of key major media news stories on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.